Empresa Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Acciones
2315
CNE100005D27
Biotecnología e investigación médica
Precio de cierre
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
9,2 CNY | -3,77 % | -9,98 % | -23,21 % |
06/05 | Biocytogen firma con Biocopy un acuerdo de evaluación y posible licencia de anticuerpos TCR-mímicos | CI |
26/04 | Las pérdidas de Biocytogen Pharmaceuticals se reducen en 2023 | MT |
Resumen de negocios
Número de empleados: 1 066
Ventas por actividad
HKD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Animal Models Selling
38,1
%
| 197 | 31,7 % | 301 | 38,1 % | +53,09 % |
Pre-clinical Pharmacology and Efficacy Evaluation
27,0
%
| 205 | 33,0 % | 214 | 27,0 % | +4,37 % |
Antibody Development
24,5
%
| 148 | 23,8 % | 194 | 24,5 % | +31,70 % |
Gene-editing
10,4
%
| 71 | 11,4 % | 82 | 10,4 % | +15,64 % |
Others
0,1
%
| 1 | 0,1 % | 1 | 0,1 % | -6,07 % |
Ventas por región
HKD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
43,0
%
| 335 | 53,9 % | 341 | 43,0 % | +1,92 % |
United States
42,0
%
| 208 | 33,5 % | 333 | 42,0 % | +59,88 % |
Others
14,9
%
| 78 | 12,6 % | 118 | 14,9 % | +51,60 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Yue Lei Shen
CEO | Chief Executive Officer | - | 13/11/09 |
Liu Bin
DFI | Director of Finance/CFO | - | 05/01/20 |
Sabrina Wang
COO | Chief Operating Officer | - | 01/10/19 |
Yi Yang
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/16 |
Jia Wei Yao
BRD | Director/Board Member | 41 | 01/06/12 |
Zhi Hong Li
PRN | Corporate Officer/Principal | - | 01/03/19 |
Chao She Guo
PRN | Corporate Officer/Principal | - | 01/10/13 |
Yan Zhu
HRO | Human Resources Officer | 60 | 01/12/11 |
Wai Ching Au
SEC | Corporate Secretary | - | - |
Yong Liang Wang
SEC | Corporate Secretary | 59 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Feng Mao Hua
BRD | Director/Board Member | 56 | 01/07/21 |
Xiao Yan Liang
BRD | Director/Board Member | 58 | 01/12/20 |
Ke Xiang Zhou
BRD | Director/Board Member | 60 | - |
Yue Lei Shen
CEO | Chief Executive Officer | - | 13/11/09 |
Jian Ni
BRD | Director/Board Member | - | - |
Hai Chao Zhang
BRD | Director/Board Member | - | - |
Yan Li
BRD | Director/Board Member | - | - |
Chun Li Sun
BRD | Director/Board Member | - | - |
44 | - | ||
Jia Wei Yao
BRD | Director/Board Member | 41 | 01/06/12 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 288 616 500 | 0 | 0 | 16,99 % |
Acción B | 1 | 110 781 920 | 67 839 140 ( 61,24 %) | 0 |
Información de la empresa
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Room 1207, Building 3 88 Kechuang 6th Street
100176, Beijing
+86 10 5696 7680
http://www.bbctg.com.cnSector
Ventas por actividad
Ventas por región
Revisiones del BPA
Ganancias trimestrales - Tasa de sorpresa
Varia. 1 de ene. | Capi. | |
---|---|---|
-23,21 % | 471 M | |
+33,37 % | 50,85 mil M | |
+1,55 % | 42,82 mil M | |
+49,11 % | 42,03 mil M | |
-4,22 % | 29,55 mil M | |
+11,57 % | 26,11 mil M | |
-21,00 % | 19,13 mil M | |
+7,36 % | 13,05 mil M | |
+28,30 % | 12,16 mil M | |
+23,80 % | 12,08 mil M |
- Bolsa de valores
- Acciones
- Acción 2315
- Empresa Biocytogen Pharmaceuticals (Beijing) Co., Ltd.